EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 10 November 2022

Europe’s share of global medicines R&D shrinks by a quarter in 20 years – as sector’s declining trends continue

Learn more on efpia.eu

Europeans are facing decreased access to new medicines and the ability to take part in ground-breaking clinical trials, as research and development of new treatments increasingly moves to more ambitious life science sectors in the US and Asia.

A new report published today by Charles River Associates for EFPIA paints a challenging picture of falling competitiveness in Europe, with the global share of pharmaceutical R&D investment, clinical trials and manufacturing output all decreasing.

Read more

Blogs

Towards an anti-cancer culture: The role of National Cancer Hubs
09 November 2022 - Hugo Ricardo Soares, PhD - Anabela Isidro

Coordinating, promoting, and supporting the implementation of European cancer initiatives in Portugal Read more

Is access to quality biomarkers and NGS testing available to European cancer patients?
09 November 2022 - Kathi Apostolidis - Nicola Normanno - Audrey Wolf

Unlocking the potential of precision medicine in Europe – improving cancer care through broader access to quality biomarker... Read more

Opening remarks by Nathalie Moll at the POLITICO Health Care Summit

As Europe emerges from the COVID-19 pandemic and faces a geopolitical and energy crisis, ensuring Europe remains an innovation centre is crucial to Europe’s patients and economic resilience. Our request is that while legislators focus the revision of the pharma legislation on the regulatory review to make our region competitive again, we all commit now, to working together to find predictable, practical and timely solutions to improving access to medicines, outside of the review of legislation.

Watch the recording here.

Events

A New Era for Health Care in Cyprus: Embrace, Evaluate, Evolve
11 November 2022 (University of Nicosia, Cyprus)

Organised by KEFEA in collaboration with EFPIA. Under the auspices of the Ministry of Health of the Republic of Cyprus.... Read more

EU HEALTH SUMMIT 2022: TOWARDS AN EU HEALTH UNION
15 November 2022 (Brussels)

An EU Health Coalition event Read more

European Business Summit 2022
16 November 2022 (Egmont Palace, Brussels)

Created 20 years ago, the European Business Summit has gone from strength to strength becoming a prestigious 2-day event,... Read more

IHI Call Days - Call 3
12 December 2022 (Virtual event)

Join the webinar to get information on how to apply and to meet potential partners for consortia. Read more

Interested in the use and acceptance of digital endpoints?

WE NEED YOUR HELP to complete a survey meant to further assess the current status of digital endpoints used in drug development and to collect experience in the current environment and feedback on what the barriers and potential solutions are:
Deadline for survey completion: 15 November 2022.

What we are reading

How can we improve timely access to vaccines and strengthen immunisation systems across the...
On 09 November 2022 (Vaccines Europe)

COVID-19 has demonstrated the profound economic and social value of vaccines – from protecting public health, to ensuring... Read more

Médicaments innovants : l'Europe a perdu du terrain au niveau mondial
On 07 November 2022 (Les Echos)

La part de l'Europe dans la R&D et les essais cliniques de médicaments innovants a nettement reculé depuis vingt... Read more

Europe’s biopharma industry needs a boost to make it more competitive
On 07 November 2022 (The Irish Times)

While Ireland’s industry is healthy, the outlook is uncertain, and now is the time to establish new connections Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu